(Q82846513)
Statements
A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia (English)
Matthew C Foster
Chirag Amin
Peter M Voorhees
Hendrik W van Deventer
Kristy L Richards
Anastasia Ivanova
Jennifer Whitman
Wingkeung Michael Chiu
Nathan D Barr
31 January 2012